KAREN RABIN to Leukemia
This is a "connection" page, showing publications KAREN RABIN has written about Leukemia.
Connection Strength
0.998
-
Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study. Leukemia. 2023 05; 37(5):1138-1140.
Score: 0.460
-
Malignancy in children with trisomy 21. Oncologist. 2009 Feb; 14(2):164-73.
Score: 0.173
-
Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series. Leuk Lymphoma. 2020 12; 61(14):3515-3518.
Score: 0.097
-
Utilization of archived neonatal dried blood spots for genome-wide genotyping. PLoS One. 2020; 15(2):e0229352.
Score: 0.093
-
Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020 07; 34(7):1741-1750.
Score: 0.093
-
Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy. Blood. 2018 05 31; 131(22):2466-2474.
Score: 0.082